Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Sales | 15,027 | 3,993 | 15,257 | 3,814 | 0 |
| Gross Profit | 15,027 | 3,993 | 15,257 | 3,814 | N/A |
| Operating Expenses | 26,167 | 14,599 | 11,622 | 9,899 | 0 |
| Operating Income | -11,140 | -10,607 | 3,635 | -6,085 | N/A |
| Other Income | 18 | 1 | 21 | -28 | 0 |
| Pre-tax Income | -11,122 | -10,606 | 3,656 | -6,113 | 0 |
| Net Income Continuous | -11,122 | -10,606 | 3,656 | -6,113 | N/A |
| Net Income | $-11,122 | $-10,606 | $3,656 | $-6,113 | $N/A |
| EPS Basic Total Ops | -60.00 | -887.00 | 393.00 | -658.00 | N/A |
| EPS Basic Continuous Ops | -60.27 | -886.75 | 393.28 | -659.46 | N/A |
| EPS Diluted Total Ops | -60.00 | -887.00 | 33.00 | -658.00 | N/A |
| EPS Diluted Continuous Ops | -60.27 | -886.75 | 33.19 | -658.04 | N/A |
| EBITDA(a) | $-10,981 | $-10,473 | $3,735 | $-6,001 | $N/A |